Aug-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In examining the performance of Dosecann across different Canadian provinces, notable movements are observed in the Capsules category. In Alberta, Dosecann maintained a steady presence, ranking consistently at 11th place in May and June 2025, peaking at 9th in July before returning to 11th in August. This indicates a slight fluctuation but overall stability in this category. In contrast, British Columbia saw Dosecann's Capsules fluctuate more, with rankings moving from 7th in May to 6th in June, dipping to 8th in July, and then returning to 6th in August. Interestingly, in Ontario, the Capsules category experienced a slight decline from a consistent 8th place to 9th in August, suggesting a need for strategic adjustments to regain momentum.
In the Topical category, Dosecann demonstrated strong and consistent performance in both British Columbia and Ontario, consistently holding the 5th and 4th positions, respectively, across all months from May to August 2025. This consistency highlights Dosecann's solid footing in the Topical market within these provinces. However, the Vapor Pens category in Ontario tells a different story, where Dosecann did not rank in the top 30, indicating a significant gap in market presence that could be an area of potential growth if addressed appropriately. The sales figures for Vapor Pens in Ontario, while not disclosed in detail here, suggest some variability, hinting at potential market challenges or opportunities for Dosecann to explore further.
Competitive Landscape
In the competitive landscape of the Ontario capsules market, Dosecann has maintained a consistent presence, though it experienced a slight decline in rank from 8th to 9th place by August 2025. This shift coincides with a downward trend in sales, dropping from $53,285 in May to $43,572 in August. Notably, Decimal consistently held the 7th rank, outperforming Dosecann with significantly higher sales figures throughout this period. Meanwhile, Simply Bare re-entered the top 10 in July and August, suggesting a resurgence that could challenge Dosecann's position further. Stigma Grow closely followed Dosecann, maintaining a rank of 9th until August when it dropped to 10th, indicating a competitive pressure from below. These dynamics highlight the competitive pressures Dosecann faces, necessitating strategic adjustments to regain its footing in the market.
Notable Products
In August 2025, the top-performing product for Dosecann was CBD Oil (30ml) in the Oil category, maintaining its first-place ranking from July with sales of 1565 units. Following closely in second place were the CBD 50 Capsules 30-Pack (1500mg CBD), which saw a slight decline in sales and rank since May, where it originally held the top spot. The CBD/THC Daily Relief Cream (1200mg CBD, 40mg THC, 60ml) consistently ranked third over the past four months, indicating stable performance in the Topical category. Indica Blackberry Cream Distillate Disposable Pen (0.3g) held steady in fourth place, showing a slight increase in sales from the previous month. Lastly, CBD Capsules 30-Pack (750mg CBD) remained in fifth place for the second consecutive month, following its introduction in June.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.